about bpl

Bio Products Laboratory Ltd.

BPL donates Replenine®-VF to help Syrian refugee

Date added: Tuesday 25th March 2014
Latest updated: Wednesday 8th February 2017

Bio Products Laboratory is pleased to announce that, in conjunction with its local partner, Munir Sukhtian Group Co., a donation of Replenine-VF (Factor IX concentrate) has been made through the Syrian relief charity, Help Syrians, to provide life-saving treatment for Zaid, a teenage boy affected by Haemophilia B, a rare, life-long bleeding disorder.

BPL was pleased to be able to respond to the request, providing Zaid with the critical therapy he needed to treat a life-threatening head bleed. Since leaving Syria for Jordan, it has been difficult for Zaid to receive his regular treatment.

Replenine-VF is BPL's triple-virus inactivated factor IX concentrate, licensed for the treatment and prophylaxis of bleeding in patients with haemophilia B (factor IX deficiency).

 UK/R9/0214/0001  Date of Preparation: February 2014

Patient information leaflets